Iconovo inhaled vaccine project wins Lund University 2015 Innovation award

Swedish DPI specialist Iconovo has won the 2015 Lund University Innovation System Innovation Prize, which comes with a SEK 150,000 award, the Lund Life Science Incubator has announced. Iconovo’s winning project, titled, “ICOone for inhaled vaccines” uses the company’s unit dose disposable dry powder inhaler platform for delivery of shelf stable vaccines.

Iconovo CEO Orest Lastow commented, “We are extremely pleased that inhaled vaccine has received this attention. I hope this will encourage others to conduct research on inhaled medicinal products.”

Lund Life Science Incubator CEO Ebba Fåhraeus said, “We are extremely proud and pleased about the level of innovation that the companies in the incubator demonstrate and the fact that Iconovo has now won first prize in the Innovation Award competition confirms this achievement. Our unique ecosystems and especially our collaboration with Lund University researchers create a large inflow of unique ideas that may lead to future global companies.”

Read the Lund Life Science Incubator press release.

Share

published on

Featured event:

October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden

October 21-October 22: MVIC Symposium, Lund, Sweden

October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany

November 10-November 11: Rescon Europe 2026, Porto, Portugal